• 1
    Knobel D.L., Cleaveland S., Coleman P.G., Fèvre E.M., Meltzer M.I., Miranda M.E., Shaw A., Zinsstag J., Meslin F.X. (2005) Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83: 3608.
  • 2
    Akira S., Uematsu S., Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell 124: 783801.
  • 3
    Randall R.E., Goodbourn S. (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 147.
  • 4
    Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., Hartmann G. (2006) 5'-Triphosphate RNA is the ligand for RIG-I. Science 314: 9947.
  • 5
    Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., Coch C., Janke M., Mihailovic A., Wardle G., Juranek S., Kato H., Kawai T., Poeck H., Fitzgerald K.A., Takeuchi O., Akira S., Tuschl T., Latz E., Ludwig J., Hartmann G. (2009) Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 2534.
  • 6
    Daffis S., Samuel M.A., Keller B.C., Gale M., Jr., Diamond M.S. (2007) Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog 3: e106.
  • 7
    Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., Michiels T. (2006) Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci USA 103: 783540.
  • 8
    Finke S., Conzelmann K.K. (2005) Replication strategies of rabies virus. Virus Res 111: 12031.
  • 9
    Ito N., Moseley G.W., Blondel D., Shimizu K., Rowe C.L., Ito Y., Masatani T., Nakagawa K., Jans D.A., Sugiyama M. (2010) Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J Virol 84: 6699710.
  • 10
    Vidy A., Chelbi-Alix M., Blondel D. (2005) Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol 79(14): 41120.
  • 11
    Vidy A., El Bougrini J., Chelbi-Alix M.K., Blondel D. (2007) The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 81: 425563.
  • 12
    Brzózka K., Finke S., Conzelmann K.K. (2005) Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79: 767381.
  • 13
    Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Sawaki Y., Koyama H., Sugiyama M. (2010) Rabies virus nucleoprotein functions to evade activation of RIG-I-mediated antiviral response. J Virol 84: 400212.
  • 14
    Shimizu K., Ito N., Mita T., Yamada K., Hosokawa-Muto J., Sugiyama M., Minamoto N. (2007) Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res 123: 15460.
  • 15
    Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Sawaki Y., Koyama H., Sugiyama M. (2011) Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity. Virus Res 155: 16874.
  • 16
    Minamoto N., Tanaka H., Hishida M., Goto H., Ito H., Naruse S., Yamamoto K., Sugiyama M., Kinjo T., Mannen K., Mifune K. (1994) Linear and conformation-dependent antigenic sites on the nucleoprotein of rabies virus. Microbiol Immunol 38: 44955.
  • 17
    Dietzschold B., Wiktor T.J., Trojanowski J.Q., Macfarlan R.I., Wunner W.H., Torres-Anjel M.J., Koprowski H. (1985) Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol 56: 128.
  • 18
    Jackson A.C., Rasalingam P., Weli S.C. (2006) Comparative pathogenesis of recombinant rabies vaccine strain SAD-L16 and SAD-D29 with replacement of Arg333 in the glycoprotein after peripheral inoculation of neonatal mice: less neurovirulent strain is a stronger inducer of neuronal apoptosis. Acta Neuropathol 111: 3728.
  • 19
    Takayama-Ito M., Inoue K., Shoji Y., Inoue S., Iijima T., Sakai T., Kurane I., Morimoto K. (2006) A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein. Virus Res 119: 20815.
  • 20
    Goody R.J., Beckham J.D., Rubtsova K., Tyler K.L. (2007) JAK-STAT signaling pathways are activated in the brain following reovirus infection. J Neurovirol 13: 37383.
  • 21
    Delgado-Vega A.M., Alarcón-Riquelme M.E., Kozyrev S.V. (2010) Genetic associations in type I interferon related pathways with autoimmunity. Arthritis Res Ther 12 (Suppl 1): S2.